Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Dishman Group | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Dishman Group

Chris Oates has been appointed chief operating officer of the Dishman Group.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Chris Oates has been appointed chief operating officer of the Dishman Group. Mr. Oates will report to Nick Green, president of the Dishman global contract research and manufacturing services (CRAMS) business. He will be responsible for Indian and Chinese operations. Mr. Oates will also manage the development, operation and improvement of the systems in the two manufacturing sites in India (Bavla and Naroda) and the new Shanghai facility, scheduled for completion mid-2010. He will be responsible for the nine operating units at Bavla, including a large-scale high potency facility that will be inaugurated in January 2010. He will play a pivotal role in expanding the company’s core CRAMS business.

Mr. Oates has more than 20 years of pharmaceutical industry experience in both production and operational roles in contract manufacturing. Most recently he served as managing director of Uquifa Mexico. His previous experience includes six years at Avecia Pharmaceuticals in the UK, where he served as operations manager, and as senior production manager for Syngenta (Agrochemicals).

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters